Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Dexamethasone-Friend or Foe for Patients With Glioblastoma?

Wong ET, Swanson KD.

JAMA Neurol. 2019 Jan 22. doi: 10.1001/jamaneurol.2018.4530. [Epub ahead of print] No abstract available.

PMID:
30667471
2.

Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis.

Kepes JJ.

Neurosurgery. 2003 May;52(5):1242. No abstract available.

PMID:
12728949
3.

[Microbial "friend-foe" identification in human intestine microsymbiocenosis].

Bukharin OV, Petrunova NB.

Zh Mikrobiol Epidemiol Immunobiol. 2011 Nov-Dec;(6):46-51. Russian.

PMID:
22308727
4.

Clinical end points in recurrent glioblastoma: are antiangiogenic agents friend or foe?

Franceschi E, Brandes AA.

Expert Rev Anticancer Ther. 2011 May;11(5):657-60. doi: 10.1586/era.11.44. No abstract available.

PMID:
21554036
5.

FRIEND or FOE: A prospective evaluation of risk factors for reintubation in surgical and trauma patients.

Michetti CP, Griffen MM, Teicher EJ, Rodriguez JL, Seoudi H, Liu C, Lita E, Newcomb A.

Am J Surg. 2018 Dec;216(6):1056-1062. doi: 10.1016/j.amjsurg.2018.07.004. Epub 2018 Jul 10.

PMID:
30017306
6.

Dexamethasone-sensitive and -insensitive responses during in vitro differentiation of Friend erythroleukemia cells.

Tsiftsoglou AS, Wong W, Housman DE.

Biochim Biophys Acta. 1983 Sep 13;759(3):160-9.

PMID:
6882797
7.
8.

Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis.

Raza SM, Lang FF, Aggarwal BB, Fuller GN, Wildrick DM, Sawaya R.

Neurosurgery. 2002 Jul;51(1):2-12; discussion 12-3. Review.

PMID:
12182418
9.

Autophagy in endometriosis: Friend or foe?

Zhan L, Li J, Wei B.

Biochem Biophys Res Commun. 2018 Jan 1;495(1):60-63. doi: 10.1016/j.bbrc.2017.10.145. Epub 2017 Oct 28. Review.

PMID:
29107692
10.

[Hypothesis of "immunological testing" of partners--systems of "friend and foe" recognition in historical prospect].

Markov AV, Kulikov AM.

Izv Akad Nauk Ser Biol. 2006 Jul-Aug;(4):389-403. Review. Russian.

PMID:
17022471
11.

Dinucleoside polyphosphates-friend or foe?

McLennan AG.

Pharmacol Ther. 2000 Aug-Sep;87(2-3):73-89. Review.

PMID:
11007992
12.

Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.

Luedi MM, Singh SK, Mosley JC, Hassan ISA, Hatami M, Gumin J, Andereggen L, Sulman EP, Lang FF, Stueber F, Fuller GN, Colen RR, Zinn PO.

J Neurosurg. 2018 Dec 1;129(6):1446-1455. doi: 10.3171/2017.7.JNS17668.

PMID:
29328002
13.

Infection in systemic lupus erythematosus: friend or foe?

Francis L, Perl A.

Int J Clin Rheumtol. 2010 Feb 1;5(1):59-74.

14.

Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma.

Wong ET, Lok E, Gautam S, Swanson KD.

Br J Cancer. 2015 Jul 14;113(2):232-41. doi: 10.1038/bjc.2015.238. Epub 2015 Jun 30. Erratum in: Br J Cancer. 2015 Dec 1;113(11):1642.

15.

Analysis of the antitumoral mechanisms of lipopolysaccharide against glioblastoma multiforme.

Won EK, Zahner MC, Grant EA, Gore P, Chicoine MR.

Anticancer Drugs. 2003 Jul;14(6):457-66.

PMID:
12853889
16.

Sulfur dioxide: foe or friend for life?

Wang XB, Cui H, Liu X, Du JB.

Histol Histopathol. 2017 Dec;32(12):1231-1238. doi: 10.14670/HH-11-904. Epub 2017 May 19. Review.

PMID:
28524210
17.

CD24 as a Novel Predictive Biomarker in Patients with Hepatocellular Carcinoma: Friend or Foe?

Machairas N, Tsilimigras DI, Moris D.

J Invest Surg. 2018 Dec 21:1-2. doi: 10.1080/08941939.2018.1538399. [Epub ahead of print] No abstract available.

PMID:
30574819
18.

What's in a name: friend or foe? Coping strategies used by stoma patients.

Powell J.

Br J Nurs. 2018 Mar 8;27(5):S22. doi: 10.12968/bjon.2018.27.5.S22. No abstract available.

PMID:
29517325
19.

Alcohol for patients with non-alcoholic fatty liver disease: friend or foe?

Kumar R.

Natl Med J India. 2011 Sep-Oct;24(5):290-1. No abstract available.

PMID:
22680081
20.

Delivery of hypoxia and glioma dual-specific suicide gene using dexamethasone conjugated polyethylenimine for glioblastoma-specific gene therapy.

Kim HA, Park JH, Yi N, Lee M.

Mol Pharm. 2014 Mar 3;11(3):938-50. doi: 10.1021/mp4006003. Epub 2014 Feb 3.

PMID:
24467192

Supplemental Content

Support Center